Insulin Inhibits Acetylcholine Responses in Rat Isolated Mesenteric Arteries via a Non-Nitric Oxide Nonprostanoid Pathway

Hyperinsulinemia is a risk factor for hypertension and arteriosclerosis. The mechanism by which it contributes to disease progression is not known. The present study examines the effects of insulin on endothelium-derived relaxing factors. Segments of rat mesenteric arterioles and aorta were set up for isometric recordings. The effect of insulin (1 mU/mL) on acetylcholine responses was examined with and without nitro-l-arginine, indomethacin, KCl (40 mmol/L), and apamin+charybdotoxin. Incubation with insulin (maximum response to acetylcholine 90.9±8.7% versus 90.7±4.5% for before versus after insulin, respectively), nitro-l-arginine, indomethacin, or high K+ alone had no effect on these responses in mesenteric arterioles. Apamin+charybdotoxin significantly blunted responses to acetylcholine. When coincubated with nitro-l-arginine but not with indomethacin or high K+, insulin blunted the maximum response to acetylcholine (from 84.8±8.2% to 40.7±10.2% for before versus after insulin, respectively;P <0.01). When coincubated with apamin+charybdotoxin, insulin had no further effect. Coadministration of indomethacin with nitro-l-arginine had no greater effect than did nitro-l-arginine alone. The addition of insulin, together with nitro-l-arginine and indomethacin, significantly decreased the maximal response to acetylcholine from 96.6±5.3% to 52.9±10.8% (P <0.01). In the aorta, nitro-l-arginine abolished acetylcholine responses. Coadministration with insulin had no further effect. We conclude that insulin attenuates acetylcholine responses mediated by endothelium-derived hyperpolarizing factor in small but not large arteries. This effect of insulin is apparent only when NO is blocked and may be important in the development of hypertension or arteriosclerosis when reduced NO function has been reported.

[1]  K. Ohashi,et al.  Inhibitory effect of insulin on bradykinin‐induced venodilation , 2000, Journal of hypertension.

[2]  M. Ujhelyi,et al.  EDHF-mediated relaxation is impaired in fructose-fed rats. , 1999, Journal of cardiovascular pharmacology.

[3]  A. Dart,et al.  Lipids and the endothelium. , 1999, Cardiovascular research.

[4]  R. Cannon,et al.  Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. , 1998, Hypertension.

[5]  R. Rizza,et al.  Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. , 1998, Hypertension.

[6]  L. Ragolia,et al.  Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. , 1998, The American journal of physiology.

[7]  M. Hoenig,et al.  Mechanisms of Impaired Endothelial Function Associated with Insulin Resistance , 1998, Journal of cardiovascular pharmacology and therapeutics.

[8]  Y. Gomita,et al.  Involvement of calcitonin gene‐related peptide (CGRP) receptors in insulin‐induced vasodilatation in mesenteric resistance blood vessels of rats , 1998, British journal of pharmacology.

[9]  A. Adeagbo,et al.  Calcium-Dependent Phospholipase A2 Mediates the Production of Endothelium-Derived Hyperpolarizing Factor in Perfused Rat Mesenteric Prearteriolar Bed , 1998, Journal of Vascular Research.

[10]  A. Takeshita,et al.  Importance of endothelium-derived hyperpolarizing factor in human arteries. , 1997, The Journal of clinical investigation.

[11]  Y Nishikawa,et al.  Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1997, Circulation.

[12]  R Busse,et al.  Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.

[13]  P. Raskin,et al.  Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. , 1996, American journal of hypertension.

[14]  M. Fujishima,et al.  The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. , 1996, Journal of cardiovascular pharmacology.

[15]  L. Ghiadoni,et al.  Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. , 1996, Circulation.

[16]  S. Hunt,et al.  Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? , 1996, Current opinion in lipidology.

[17]  N. Kaplan The deadly quartet and the insulin resistance syndrome: an historical overview. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.

[18]  E. Ferrannini,et al.  Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[19]  L. Blatter,et al.  Simultaneous measurements of Ca2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. , 1995, Circulation research.

[20]  A. Quyyumi,et al.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. , 1995, Circulation.

[21]  T. Saruta,et al.  Multiple factors contribute to acetylcholine-induced renal afferent arteriolar vasodilation during myogenic and norepinephrine- and KCl-induced vasoconstriction. Studies in the isolated perfused hydronephrotic kidney. , 1994, Circulation research.

[22]  D. Webb,et al.  Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. , 1994, British journal of clinical pharmacology.

[23]  T. Wascher,et al.  Endothelial dysfunction in hypertension , 1994, The Lancet.

[24]  T. Cocks,et al.  Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium‐dependent relaxation of pig isolated coronary artery , 1994, British journal of pharmacology.

[25]  R. Busse,et al.  Signal transduction in endothelium-dependent vasodilatation. , 1993, European heart journal.

[26]  R. Feldman,et al.  Insulin-mediated vasodilation: impairment with increased blood pressure and body mass , 1993, The Lancet.

[27]  J. McEwan,et al.  Bradykinin‐induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine‐sensitive kinase , 1993, British journal of pharmacology.

[28]  J. McEwan,et al.  Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells , 1992, British journal of pharmacology.

[29]  G. Rubanyi Endothelium‐derived relaxing and contracting factors , 1991, Journal of cellular biochemistry.

[30]  M. Mulvany,et al.  Mechanical properties of vascular smooth muscle cells in situ , 1976, Nature.

[31]  W. Kannel,et al.  Risk stratification in hypertension: new insights from the Framingham Study. , 2000, American journal of hypertension.

[32]  T. Awata,et al.  Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension , 2000, Journal of hypertension.

[33]  J. Connell,et al.  Insulin-mediated vasodilation and glucose uptake are functionally linked in humans. , 1999, Hypertension.

[34]  M. Clark,et al.  Role of blood flow in the regulation of muscle glucose uptake. , 1997, Annual review of nutrition.

[35]  J. T. ter Maaten,et al.  Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. , 1997, Clinical science.